The Luisier Group focuses on developing cutting-edge AI technologies to multimodal data in collaboration with experts labs in AI and clinicians with the aim to unravel the intricate molecular and cellular mechanisms driving neurodegenerative diseases and cancer, paving the way for innovative therapeutic strategies
